| 产品描述: | MMP抑制剂;MMP Inhibitors;;InformationT-26c T-26c is a highly potent and selective inhibitor of matrix metalloproteinase-13 (MMP-13) with IC50 of 6.9 pM, more than 2600-fold selectivity over other related metalloenzymes.TargetsMMP-13 (Cell-free assay) 6.9 pM |
| 靶点: |
IC50: 6.75 pM (MMP-13) |
| 体内研究: |
T-26c 以 10-20 mg/kg 的口服剂量在所有物种中均能很好地吸收。与游离酸相比,豚鼠口服 T-26c 二钠盐制剂可显著增加 AUC (8357 ng h/mL) 和 Cmax (1445 ng/mL) T-26c (AUC=6478 ng h/mL 和 Cmax= 911 ng/mL)。 |
| 参考文献: |
1. Nara H, et al. Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site. Bioorg Med Chem. 2014 Oct 1;22(19):5487-505. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.085 ml |
10.427 ml |
20.855 ml |
| 5 mM |
0.417 ml |
2.085 ml |
4.171 ml |
| 10 mM |
0.209 ml |
1.043 ml |
2.085 ml |
| 50 mM |
0.042 ml |
0.209 ml |
0.417 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |